Follow-up on paper in last post…

There’s a big ‘debate’ about off-label drugs being used as treatments for COVID-19. If one wishes to determine whether or not a drug ‘works’ or not, one might compare the frequency of ‘bad’ outcomes in treated versus non-treated groups.1 I published a Substack article yesterday and stated that a recent paper claiming that 1טeרmEכזiה did not prevent subsequent progression to severe disease in people with mild to moderate COVID-19, actually showed that 1טeרmEזכiה prevented death as a secondary outcome.

Had death been chosen as part of ‘progression to severe disease outcome’ (the primary outcome), then the study would definitively have shown that 1טeרmEזכiה was a successful drug with regard to mild to moderate COVID-19 treatment.

LINK